Eurofins Scientific SE Stock Deutsche Boerse AG
Stocks
ESF0
FR0014000MR3
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 70.17 EUR | +1.61% |
|
+1.41% | +13.72% |
| 06-30 | NFL Biosciences validates industrial-scale production of NFL-102 for smoking cessation |  |
| 06-23 | Eurofins Scientific SE acquired Weatherbys Scientific. | CI |
| Market Cap | 12.15B 13.89B 11.23B 10.31B 19.51B 1,339B 19.85B 134B 52.62B 654B 52.18B 51.03B 2,257B | P/E 2026 * |
24.1x | P/E 2027 * | 18.5x |
|---|---|---|---|---|---|
| Enterprise Value | 15.59B 17.83B 14.42B 13.23B 25.03B 1,718B 25.47B 172B 67.53B 839B 66.97B 65.5B 2,897B | EV / Sales 2026 * |
2.05x | EV / Sales 2027 * | 1.89x |
| Free-Float |
58.35% | Yield 2026 * |
1.11% | Yield 2027 * | 1.29% |
Last Transcript: Eurofins Scientific SE
| 1 day | +1.56% | ||
| 1 week | +1.41% | ||
| Current month | +2.50% | ||
| 1 month | +13.94% | ||
| 3 months | +1.91% | ||
| 6 months | -1.53% | ||
| Current year | +13.72% |
| 1 week | 67.68 |  | 70.6 |
| 1 month | 61.98 | | 70.6 |
| Current year | 57.06 | | 73.92 |
| 1 year | 56.54 | | 73.92 |
| 3 years | 40 | | 73.92 |
| 5 years | 40 | | 129.2 |
| 10 years | 29.22 | | 681.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CEO | Chief Executive Officer | 63 | 1986-12-31 |
Laurent Lebras
DFI | Director of Finance/CFO | - | 2014-12-31 |
Christian Wurst
PRN | Corporate Officer/Principal | 53 | 2019-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CHM | Chairman | 63 | 1986-12-31 |
Yves-Loïc Martin
BRD | Director/Board Member | 60 | 2014-12-31 |
Valérie Hanote
BRD | Director/Board Member | 60 | 1989-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.61% | +1.41% | - | - | 13.89B | |
| -1.69% | -3.00% | -0.28% | +5.03% | 49.7B | |
| +1.97% | -2.15% | +368.30% | +587.22% | 38.09B | |
| -1.40% | +4.01% | +7.01% | +56.99% | 35.29B | |
| -0.97% | +1.05% | +28.66% | -5.12% | 35.13B | |
| +0.06% | +1.56% | +4.41% | +27.42% | 27.22B | |
| +1.94% | -2.61% | - | - | 16.14B | |
| -0.20% | -0.66% | +67.52% | +116.15% | 15.36B | |
| -0.98% | +0.51% | +14.77% | -31.21% | 13.02B | |
| +0.17% | -2.77% | +1,275.14% | +651.57% | 11.76B | |
| Average | +0.10% | -0.98% | +220.69% | +176.01% | 26.86B | |
| Weighted average by Cap. | -0.17% | -0.84% | +140.18% | +151.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.6B 8.69B 7.03B 6.45B 12.21B 838B 12.42B 83.82B 32.93B 409B 32.65B 31.93B 1,412B | 8.07B 9.24B 7.47B 6.85B 12.97B 890B 13.19B 89.05B 34.98B 435B 34.69B 33.93B 1,501B |
| Net income | 517M 591M 478M 438M 830M 56.96B 844M 5.7B 2.24B 27.81B 2.22B 2.17B 96.03B | 676M 774M 625M 574M 1.09B 74.54B 1.1B 7.46B 2.93B 36.4B 2.9B 2.84B 126B |
| Net Debt | 3.44B 3.94B 3.18B 2.92B 5.53B 379B 5.62B 37.96B 14.91B 185B 14.79B 14.46B 640B | 3.08B 3.53B 2.85B 2.62B 4.95B 340B 5.04B 34.02B 13.36B 166B 13.25B 12.96B 573B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-17 | €70.60 | +2.23% | 0 |
| 26-07-16 | €69.06 | -0.40% | 0 |
| 26-07-15 | €69.34 | +0.78% | 0 |
| 26-07-14 | €68.80 | -0.03% | 0 |
| 26-07-13 | €68.82 | -1.15% | 0 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ERF Stock
- ESF0 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
